Inflammatory Bowel Disease - Diagnostic and Therapeutic Strategies

G. Adler, C. Fiocchi, L.B. Lazebnik, G.I. Vorobjev (Herausgeber)

Buch | Hardcover

237 Seiten

2007 | 2007 ed.
Springer-Verlag New York Inc.
978-1-4020-6115-8 (ISBN)

Titel ist leider vergriffen;
keine Neuauflage

Artikel merken

This book records the proceedings of the Falk Symposium 154 held in Moscow, Russia, on June 9–10 2006. It presents the most recent progress in our current understanding of the mechanisms of inflammatory bowel disease, the therapeutic state of the art, and future options of treatment. The authors and editors are a selected group of international experts, who contribute their wide experience of the mechanisms and management of IBD.

From the Contents List of principal contributors List of chairpersons Preface SECTION I: MECHANISMS OF INFLAMMATORY BOWEL DISEASE: 1st SESSION.- 1 State-of-the-Art Lecture: The multifactorial pathogenesis of inflammatory bowel disease.- 2 CD1d: at the cusp of innate and adaptive immunity in regulating mucosal inflammation.- 3 Control of mucosal immune responses by transforming growth factor-beta.- 4 Immunoregulation: Crohn's disease versus ulcerative colitis.- 5 Role of Toll-like receptors in inflammatory bowel diseases.- 6 Animal models in inflammatory bowel disease.- 7 Epidemiology of inflammatory bowel disease in Russia.- SECTION II: MECHANISMS OF INFLAMMATORY BOWEL DISEASE: 2nd SESSION.- 8 State-of-the-Art Lecture: Genetics and genomics: implications for clinical practice.- 9 Genetic factors in the inflammatory bowel disease.- 10 Genotype-based classification of inflammatory bowel disease phenotype.- 11 Role of the intestinal barrier in inflammatory bowel disease.- SECTION III: MANAGEMENT OF INFLAMMATORY BOWEL DISEASE: 1st SESSION.- 12 Histological evaluation of activity of the ulcerative colitis in its initial stage of development.- 13 Crohn's disease of the small intestine: versions of clinical picture and problems of differential diagnosis.- 14 Distal colitis as a special pattern of ulcerative colitis.- 15 Implications of dysplasia in the prevention of ulcerative colitis-associated colo.- 16 The chemopreventive effect of aminosalicylates.- 17 The role of antibiotics and probiotics in Crohn's disease.- SECTION IV: MANAGEMENT OF INFLAMMATORY BOWEL DISEASE: 2nd SESSION.- 18 Indications for use of infliximab in inflammatory bowel disease.- 19 Therapy of inflammatory bowel disease: step-up or top-down.- 20 State of the Art Lecture: Emerging biologic therapies.- 21 Surgical treatment of complications of Crohn's disease.- 22 Surgical treatment of ulcerative colitis.- Index

Erscheint lt. Verlag	17.4.2007
Reihe/Serie	Falk Symposium ; 154
Zusatzinfo	XIII, 237 p.
Verlagsort	New York, NY
Sprache	englisch
Maße	155 x 235 mm
Themenwelt	Medizinische Fachgebiete ► Innere Medizin ► Gastroenterologie
ISBN-10	1-4020-6115-3 / 1402061153
ISBN-13	978-1-4020-6115-8 / 9781402061158
Zustand	Neuware